| Peptide | What It Is / Research Focus | Regulatory Status |
|---|---|---|
| BPC-157"Body Protection Compound" | A synthetic peptide fragment studied for tissue repair, gut-lining support, and angiogenesis in lab/animal research. | Research-Use-Only FDA flagged as Category 2 (safety risk) for compounding |
| TB-500 / TB-4Thymosin Beta-4 | A synthetic version of a naturally occurring protein, studied for tissue regeneration and flexibility/recovery research. | Research-Use-Only |
| KPVα-MSH fragment | A tripeptide studied for anti-inflammatory and immune-modulation pathways. | Research-Use-Only |
| Peptide | What It Is / Research Focus | Regulatory Status |
|---|---|---|
| GHK-CuCopper Tripeptide-1 | A copper-binding peptide widely used in topical skincare; studied for collagen/elastin signaling, antioxidant activity, and skin-barrier support. | Cosmetic / Topical Common in serums; injectable use is research-only |
| Palmitoyl peptidese.g. Matrixyl / pentapeptides | A family of cosmetic peptides found in anti-aging skincare; marketed for the appearance of fine lines. | Cosmetic / Topical |
| ArgirelineAcetyl Hexapeptide-8 | A topical cosmetic peptide marketed for the look of expression lines. | Cosmetic / Topical |
| Peptide | What It Is / Research Focus | Regulatory Status |
|---|---|---|
| SemaglutideGLP-1 receptor agonist | The peptide behind well-known FDA-approved diabetes and weight-management medications. | FDA-Approved exists Brand medications are approved; compounding now restricted |
| TirzepatideGIP / GLP-1 agonist | A dual-pathway peptide behind FDA-approved diabetes and weight medications. | FDA-Approved exists Off shortage list since Oct 2024; compounding restricted |
| AOD-9604GH fragment 176-191 | A fragment of growth hormone studied for fat-metabolism pathways without broader hormonal effects. | Research-Use-Only |
| MOTS-c | A mitochondrially-derived peptide studied for metabolic regulation, AMPK activation, and energy research. | Research-Use-Only |
| Peptide | What It Is / Research Focus | Regulatory Status |
|---|---|---|
| Sermorelin | A growth-hormone-releasing hormone analog historically studied for endogenous GH stimulation. | FDA-Approved exists Previously approved; now primarily compounded |
| Tesamorelin | A GHRH analog; an FDA-approved brand exists for a specific indication. Studied for body composition and lipid research. | FDA-Approved exists |
| CJC-1295often "No DAC" | A GHRH analog studied as a GH secretagogue in research settings. | Research-Use-Only |
| Ipamorelin | A selective GH secretagogue frequently referenced alongside CJC-1295 in optimization research. | Research-Use-Only |
| Peptide | What It Is / Research Focus | Regulatory Status |
|---|---|---|
| EpithalonEpitalon | A synthetic tetrapeptide studied for telomerase activity and circadian-rhythm research. | Research-Use-Only |
| Thymalin | A thymus-derived peptide preparation studied for immune-function research. | Research-Use-Only |
| FOXO4-DRI | A research peptide studied in the context of senescent-cell biology. Early-stage lab research only. | Research-Use-Only |
| NAD+technically a coenzyme | Not a peptide, but frequently grouped with this category; studied for cellular energy and used in some IV wellness settings. | Research-Use-Only Status varies by form/route |
| Peptide | What It Is / Research Focus | Regulatory Status |
|---|---|---|
| Selank | A synthetic peptide studied for anxiolytic and stress-related pathways in research. | Research-Use-Only |
| Semax | A synthetic peptide studied for BDNF and cognitive/neuroprotective research. | Research-Use-Only |
| PT-141Bremelanotide | A melanocortin peptide; an FDA-approved brand exists for a specific sexual-health indication. | FDA-Approved exists |
| MT-IIMelanotan II | A melanocortin peptide studied for melanin and appetite pathways. | Research-Use-Only FDA has warned about unapproved versions |